• No results found

Processing of the envelope glycoprotein gp160 in immunotoxin-resistant cell lines chronically infected with human immunodeficiency virus type 1.

N/A
N/A
Protected

Academic year: 2019

Share "Processing of the envelope glycoprotein gp160 in immunotoxin-resistant cell lines chronically infected with human immunodeficiency virus type 1."

Copied!
10
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

TABLE 1. Immunotoxin-resistant variants characterized in this study
FIG. 1. Sensitivity of variant cells to immunotoxins. Cells were grown in the presence of immunotoxins for 2 days, labeled overnight with [35harvested
FIG. 2. Intracellular expression of HIV proteins. Harvested cells were permeabilized with Triton X-100 and stained HIVIG, followed by a FITC-conjugatedsecondary antiserum
FIG. 3. HIV protein profile. Protein (100 �12.5% polyacrylamide gel and transferred to a nitrocellulose membrane
+4

References

Related documents

Depletion of TIP47 in Jurkat cells does not disrupt HIV-1 Env incorporation, virus release, infectivity, or replication.. We previously demonstrated that the requirement for the gp41

This antagonism of particle release restriction appears to closely correlate with the ability of the HIV-2 Env to mediate cell surface downregulation of tetherin expression..

We characterized human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein epitopes recognized by neutralizing antibodies from monkeys recently infected by molecularly

Cells were stained with the anti-CD4 MAb or with the anti-CD8 MAb as a control and analyzed by flow cytometry (Fig. In cells infected with the control vector, surface levels of CD4

The envelope (env) gene of the human immunodeficiency virus type 1 (HIV-1) encodes the gp160 glycoprotein, which is cleaved in the host cell to produce the gpl20 surface and the

findings described in Table 1 clearly demonstrate that all five hepatoma cell lines were susceptible to productive infection by HIV-1 in vitro. HIV-1 infection of hepatoma cells is

Extracts from infected cells (panel CELL) and from culture medium containing virus particles (panel SN) were purified on HIV-2 serum-Sepharose to identify the viral glycoproteins

immunization of an HIV-1 IIIB-based recombinant gp160 (rgp160) experimental vaccine were evaluated for rgp160-specific antibodies in parotid saliva, genital secretions, and serum..